SELLAS Life Sciences Group, Inc. (SLS) Most Active Options

The 25 most actively traded SELLAS Life Sciences Group, Inc. (SLS) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$14.36
52-week range
$1.40 – $15.47
ATM IV (30d)
172.6%
IV rank
22 / 100
Low
Expected move
±$7.34 (±51.1%)
Put/call OI
0.47
Call-heavy
Max pain
$5
↓ 65.2% below close
Next earnings
Nov 11, 2026

Most Active SLS Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
SLS $30 call Jan 15, 2027 144d $4.10 199.8% 67 0.52 67,804 8,849 34.5× avg
SLS $15 call Jan 21, 2028 515d $8.57 141.7% 11 0.80 5,094 2,715 2.7× avg
SLS $30 call Jan 21, 2028 515d $6.30 137.9% 16 0.66 7,979 2,592 10.1× avg
SLS $15 call Aug 28, 2026 4d $0.80 151.7% 61 0.43 1,992 2,148 2.2× avg
SLS $15 call Jan 15, 2027 144d $6.80 203.4% 87 0.73 36,466 1,493 1.5× avg
SLS $16 call Aug 28, 2026 4d $0.45 169.4% 65 0.30 1,393 1,389 2.2× avg
SLS $14.5 call Aug 28, 2026 4d $0.80 134.6% 43 0.50 904 1,303 1.4× avg
SLS $30 call Oct 16, 2026 53d $1.85 224.2% 30 0.33 15,480 1,230 17.0× avg
SLS $9 put Sep 18, 2026 25d $0.28 158.9% 7 -0.09 3,318 1,066 52.6× avg
SLS $15 call Sep 18, 2026 25d $2.00 151.8% 27 0.54 25,844 836 9.6× avg
SLS $20 call Aug 28, 2026 4d $0.10 226.8% 56 0.10 1,551 813 2.5× avg
SLS $23 call Aug 28, 2026 4d $0.12 281.5% 33 0.07 84 771 9.1× avg
SLS $14 call Aug 28, 2026 4d $0.95 126.2% 27 0.61 921 728 1.4× avg
SLS $13 put Aug 28, 2026 4d $0.25 141.7% 46 -0.23 1,350 680 2.3× avg
SLS $17 call Aug 28, 2026 4d $0.35 168.1% 64 0.19 603 673 1.1× avg
SLS $12.5 put Aug 28, 2026 4d $0.18 146.1% 50 -0.16 333 565 1.9× avg
SLS $14 put Aug 28, 2026 4d $0.70 139.3% 27 -0.40 150 519 1.8× avg
SLS $25 call Aug 28, 2026 4d $0.10 351.4% 54 0.09 723 493 5.8× avg
SLS $30 call Sep 18, 2026 25d $0.42 198.4% 20 0.12 19,452 478 5.2× avg
SLS $5 call Jan 15, 2027 144d $10.50 189.7% 38 0.93 64,810 459 6.8× avg
SLS $20 call Sep 18, 2026 25d $1.00 170.3% 21 0.30 4,596 410 7.0× avg
SLS $15.5 call Aug 28, 2026 4d $0.50 149.5% 46 0.34 1,168 396 0.6× avg
SLS $30 call Sep 4, 2026 11d $0.10 357.9% 60 0.19 346 3.2× avg
SLS $25 call Jan 15, 2027 144d $4.55 197.4% 65 0.57 1,534 345 1.3× avg
SLS $9 put Oct 16, 2026 53d $1.80 231.4% 29 -0.16 6,183 332 2.6× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active SLS contract today is the $30 call expiring in 144 days, with 8,849 contracts traded. Calls dominate the most-active list (20 of the top 25), showing where trading interest concentrates. 6 of these contracts are running well ahead of the usual daily volume.

Explore the payoff profile of option on SLS for free

Build multi-leg SLS strategies, visualize payoffs, and scan the full US options universe with OptiView.

SLS Options FAQ

Which SLS option contract is most active today?

The most traded SLS contract is the $30 call expiring Jan 15, 2027, with 8,849 contracts traded as of Aug 24, 2026.

How does OptiView rank the most active SLS options?

The table lists the 25 SLS contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.